Home > Research > Browse

Results for Clinical Trials, Phase III as Topic

Publications & Outputs

  1. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: Study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial

    Wang, Y., Zhou, F., Zhang, D., Zhao, J., Du, R., Hu, Y., Cheng, Z., Gao, L., Jin, Y., Luo, G., Fu, S., Lu, Q., Du, G., Wang, K., Lu, Y., Fan, G., Zhang, Y., Liu, Y., Ruan, S., Liu, W. & 5 others, Jaki, T., Hayden, F. G., Horby, P. W., Cao, B. & Wang, C., 24/05/2020, In: Trials. 21, 1, 11 p., 422.

    Research output: Contribution to journalJournal articlepeer-review

  2. Data-driven treatment selection for seamless phase II/III trials incorporating early-outcome data

    Kunz, C. U., Friede, T., Parsons, N., Todd, S. & Stallard, N., 07/2014, In: Pharmaceutical Statistics. 13, 4, p. 238-246 9 p.

    Research output: Contribution to journalJournal articlepeer-review